|Articles|February 2, 2015

ICON Acquires MediMedia Pharma Solutions

Author(s)Applied Clinical Trials Editorial Staff

ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced it has agreed, subject to certain customary closing conditions, to acquire MediMedia Pharma Solutions for a cash consideration of $120 million.

ICON

announced its intention to acquire MediMedia Pharma Solutions for $120 million. MediMedia Pharma Solutions provides strategic payer-validated market access solutions, and medical and scientific communication agencies working with medical affairs, commercial and brand development teams within life science companies. The acquisition strengthens ICON’s expertise in scientific communications and market access. Read the full release

here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!